Assessement of a Test a Financial-incentive Program for Pregnant Women and Their Smoking Partners to Reduce Smoking During Pregnancy.
NCT07528664 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2026-04-14
Summary
Nearly one in five pregnant women still smoke in the third trimester of pregnancy. This is the highest rate in Europe. Smoking during pregnancy is an established risk factor for the unborn child: risk of ectopic pregnancy, intrauterine growth restriction and prematurity, risk of sudden infant death syndrome (increased two- to threefold), and risk of respiratory problems for the newborn. The risks increase with the frequency and duration of the mother's smoking during pregnancy.
Quitting smoking is essential to prevent the risks associated with tobacco use during pregnancy. The evidence of benefits for the child from pharmacotherapeutic interventions (nicotine replacement therapy) is insufficient. New treatment options must be explored to help pregnant women quit smoking.
Financial incentives are recognized as an effective means of motivating behavior change. It is about impacting the trade-off of quitting smoking. The trade-off consists of the benefits of quitting (improved health and reduced monetary costs because tobacco is no longer purchased) and the costs of quitting (suppressing the satisfaction and pleasure derived from smoking). One consortium member conducted a large clinical trial showing that a financial incentive is an effective intervention to help pregnant women who smoke to quit smoking.
Previous studies have shown that 70% of partners of women who use tobacco are themselves smokers. The partner's smoking is a risk factor for continued tobacco use during pregnancy and can be a source of passive smoking for the mother and child. Women who quit smoking before and after pregnancy are more often in relationships with nonsmoking partners than those who continue to smoke.
The investigator hypothesize that a financial incentive aimed at the partner's abstinence from tobacco will enhance the beneficial effects of the financial incentive on reducing or stopping tobacco use during pregnancy. The investigator also hypothesize that incentivizing the partner to stop smoking will help strengthen their engagement in family life.
Conditions
- Pregnant Woman Who Uses Tobacco
Interventions
- BEHAVIORAL
-
Financial incentive contingent on tobacco abstinence.
Financial incentive conditioned on tobacco abstinence targeting the pregnant woman and the smoking partner to reduce tobacco use during pregnancy, compared with no financial incentive for the couple and with a financial incentive targeting only the pregnant woman.
- RADIATION
-
Standar care
In the control group, parental care will be in line with current practices in the maternity ward and with the recommendations of Santé publique France in force at the start of the study.
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2028-12-01
- Completion
- 2028-12-01
Countries
- France
Study Locations
More Related Trials
-
Targeted Lifestyle Change Group Prenatal Care
NCT04090307 ·Status: COMPLETED ·Phase: NA
-
Prevention of Gestational Diabetes
NCT01130012 ·Status: COMPLETED ·Phase: NA
-
Respiratory Disorder During Sleep in the Pregnancy : A Risk Factor in Gestational Diabetese
NCT02756442 ·Status: UNKNOWN ·Phase: NA
-
Blood Pressure Monitoring in High Risk Pregnancy to Improve the Detection and Monitoring of Hypertension
NCT03334149 ·Status: COMPLETED ·Phase: NA
-
Improving Prenatal Care to Reduce Early Onset Preeclampsia in Low-Income
NCT07491510 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Maternal Health Diabetes Prevention Study
NCT05343494 ·Status: COMPLETED ·Phase: NA
-
NAITRE (PreNAtal Care in deprIvaTed enviRonnEment)
NCT02402855 ·Status: COMPLETED ·Phase: NA
-
Screening for Preeclampsia With Various Markers in Low-risk Pregnancy Populations
NCT01649128 ·Status: COMPLETED
-
Early PrEgnancy Complications Testing
NCT04079361 ·Status: RECRUITING ·Phase: NA
-
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
NCT04786587 ·Status: RECRUITING
-
Preconception Lifestyle Interventions to Improve Future Metabolic Health (Before the Beginning)
NCT04585581 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effect of Lifestyle Intervention for Hypertriglyceridemia on the Pathogenesis of Adverse Pregnancy Outcome
NCT04275622 ·Status: UNKNOWN ·Phase: NA
-
Lipid Profile as Predictor of Adverse Maternal and Neonatal Outcomes: A Pilot Study
NCT05535660 ·Status: COMPLETED
-
Group Versus Traditional Prenatal Care for Diabetes
NCT03301792 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy
NCT03575286 ·Status: UNKNOWN
-
Cardiometabolic Health in First Time Pregnancy
NCT05856318 ·Status: RECRUITING
-
Med-South Lifestyle Program for Pregnancy
NCT06374199 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Education for Gestational Diabetes
NCT02528162 ·Status: COMPLETED
-
Pilot Assessment of an Auto Blood Pressure Monitor
NCT02258256 ·Status: COMPLETED ·Phase: NA
-
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
NCT00579150 ·Status: TERMINATED
-
A Novel Diet Approach to Combat Gestational Diabetes
NCT03803072 ·Status: COMPLETED ·Phase: NA
-
Self-management of Postnatal Anti-hypertensive Treatment: a Trial Development Pilot Study
NCT02333240 ·Status: COMPLETED ·Phase: NA
-
A Follow-up of the Early Pregnancy Study Cohort.
NCT01132924 ·Status: COMPLETED
-
Predictive and Protective Factors in the Cause of Diabetes - A Study in Twins
NCT00339781 ·Status: COMPLETED
-
Evolocumab Pregnancy Exposure Registry
NCT02957604 ·Status: TERMINATED